Summary Information:
STAAR Surgical Company Common Stock
NASDAQ:STAA


email
[email protected]
Our Main Pages
Stocks.TRoach.Net
TRoach.Org
TRoach.Net

NOTE: This page is for evaluation of a JFF Project.
This page is NOT updated on a regular basis.
Information on this page should NOT be used for investment purposes.


STAAR Surgical Company Common Stock
Exchange: NASDAQ
Symbol: STAA
SEC CIK: 0000718937
Phone: 6263037902
1911 WALKER AVE
MONROVIA CA 91016

CEO: Caren Mason
Price when page updated: 31.29 Date: 2023-12-01
Company Website:
www.staar.com

_Description: STAAR, which has been dedicated solely to ophthalmic surgery for over 30 years, designs, develops, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. All of these lenses are foldable, which permits the surgeon to insert them through a small incision. STAAR's lens used in refractive surgery is called an Implantable Collamer® Lens or 'ICL', which includes the EVO Visian ICL™ product line. More than 1,000,000 Visian® ICLs have been implanted to date and STAAR markets these lenses in over 75 countries. To learn more about the ICL go to: www.discovericl.com. Headquartered in Lake Forest, CA, the company operates manufacturing and packaging facilities in Aliso Viejo, CA, Monrovia, CA and Nidau, Switzerland.

IPO YEAR:

Sector:
Health Care
Industry:
Ophthalmic Goods
ADRTSO:

MarketCap:
1527498730.00
Beta:
1.715370174992984
52 Week High:
163.08
52 Week Low:
74.88
52 Week Change:
0.173411122144985
Short Interest:

Short Date:

Shares Outstanding:
47600293
Dividend Rate:
0
Dividend Yield:
N/A
ExDividend Date:

Latest EPS:

Latest EPS Date:
2 Nov 2022
Float:
0
return on Equity:
12.40%
Consensus EPS:

Number Of Estimates:

EPS Surprise Dollar:

Eps Surprise Percent:

EBITDA:
$49.278M
ttmEPS:
0.4544
Revenue:
$261.654M
Gross Profit:

Cash:

Debt:

Institution Percent:
98.90%
Revenue Percent:

Revenue Per Employee:

Insider Percent:
0.90%
Return on Assets:
9.60%
Return on Capital:

Profit Margin:
12.80%
Price to Sales:
17.56
Price To Book:
15.09
Short Ratio:
7.02
PE Ratio:
196.44004615777527
Employees:
575
1Y Guesstimate
120.499:1.0:6




__The following are links to various summary and news pages for
__STAAR Surgical Company Common Stock [ STAA ].

__Note: Some Links might not have information for the company.


finance.Yahoo.com money.CNN.com NASDAQ research
WalletInvestor.com WSJ.com MarketBeat.com
finviz.com WallMine.com TheGlobeandMail.com
stock1010.com
NASDAQ - General Info SEC Insider Report Ownership Summary
Dividend History insiderbuyingselling.com
Facebook search Twitter search LinkedIn search
PRnewsWire.Com Google Forecast
tdameritrade.com BarChart.com
SeekingAlpha.com Markets.FT.com stocktwits.com
FinTel.io Ldmicro.com bloomberg.com
MarketWatch.com Reuters.com businessinsider.com
fool.com barrons.com zacks.com
GuruFocus.com Investing.com tipranks.com
thestreet.com nytimes.com earningswhispers.com
marketchameleon.com sunshineavenue.com stockinvest.us
stockanalysis.com stockconsultant.com ycharts.com
financialcontent.com docoh.com foxbusiness.com
cnbc.com investorsobserver.com tradingview.com
investopedia.com tmxmoney.com invest.cnyes.com
ask.com bing.com brave.com
duckduckgo.com ecosia.org excite.com
exalead.com gibiru.com hotbot.com
www.info.com infospace.com lycos.com
lukol.com metacrawler.com mojeek.com
becovi.com searx.thegpm.org search.com
swisscows.com webcrawler.com yahoo.com
yandex.com yep.com you.com




INDEX




Page design by: TRoach
Page Last Updated: 2023-12-01